‘In A Word, Complicated’ – AAM’s Burton Talks US Biosimilars
Biosimilars Council Chief Sees Improvement In US Market, But Says There Is Further To Go
• By David Wallace
Craig Burton explains the complications of the US biosimilars market • Source: Shutterstock 
